TORRE ed altri: Norme sulla protezione brevettuale dei farmaci

This procedure concerns rules for the patent protection of medicinal products. It aims to ensure that pharmaceutical companies can protect their innovations, encouraging further research and development in the sector. The rules will affect pharmaceutical companies, researchers, and potentially patients by influencing the availability and cost of medicines. It ensures a balance between innovation incentives and public access to treatments.